Kpam Tablet 3 mg

Kpam Tablet, containing Bromazepam 3 mg, is a benzodiazepine-class medication manufactured by Kemiko Pharmaceuticals Ltd. Priced at ৳4.01 per unit (50’s pack: ৳200.50), it effectively manages anxiety, insomnia, and psychosomatic disorders. The tablet form ensures convenient administration for patients requiring rapid relief.

This psychotropic agent modulates GABA-A receptors, alleviating tension at low doses and providing sedation at higher doses. It addresses emotional disturbances, cardiovascular irregularities, gastrointestinal spasms, and dysmenorrhea. Dosage varies from 1.5-12 mg/day, tailored to patient age and health status. Avoid prolonged use beyond 12 weeks without medical supervision.

Common side effects include drowsiness, fatigue, and confusion. Contraindications include pregnancy, lactation, and alcohol co-consumption. Prescribers must assess drug interactions with CNS depressants. Store Kpam Tablet in dry, cool conditions away from children. Explore Bromazepam alternatives for personalized therapeutic options.

Adults: 1.5-3 mg thrice daily. Severe cases: 6-12 mg 2-3 times/day. Reduce dose in elderly/hepatic impairment. Not recommended for children. Max duration: 8-12 weeks. Administer orally with water.

Common side-effects include fatigue, drowsiness, muscle weakness, numbed muscle, reduced alertness, confusion, headache, ataxia etc. These phenomena occur predominantly at the start of therapy and usually disappear with prolonged administration. Anterograde amnesia may occur using therapeutic doses.

Pregnancy Category D. Avoid during lactation. Consult doctor for risk-benefit analysis.

Risk of dependence with prolonged use. Taper dose gradually. Avoid machinery operation. Not for primary psychiatric treatment.

Elderly: Reduce dose by 50%. Pediatric: Contraindicated. Hepatic impairment: Dose adjustment needed. Renal: Use cautiously.